Published in Neurology on January 01, 2000
GPi+NBM DBS in Parkinson's Disease With Mild Cognitive Impairment (2T-DBS) | NCT04571112
Deep brain stimulation for Parkinson's disease. Neurotherapeutics (2008) 1.53
The history and future of deep brain stimulation. Neurotherapeutics (2008) 1.11
Cognitive and behavioural effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2003) 1.03
Deep brain stimulation: technology at the cutting edge. J Clin Neurol (2010) 0.97
The treatment of movement disorders by deep brain stimulation. Neurotherapeutics (2008) 0.96
Moving forward: advances in the treatment of movement disorders with deep brain stimulation. Front Integr Neurosci (2011) 0.94
Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues Clin Neurosci (2004) 0.90
Surgical treatment of dyskinesia in Parkinson's disease. Front Neurol (2014) 0.87
High-frequency microstimulation in human globus pallidus and substantia nigra. Exp Brain Res (2010) 0.86
Somatotopic organization in the internal segment of the globus pallidus in Parkinson's disease. Exp Neurol (2010) 0.86
Effect of chronic pallidal deep brain stimulation on off period dystonia and sensory symptoms in advanced Parkinson's disease. J Neurol Neurosurg Psychiatry (2002) 0.85
Neuromodulation: selected approaches and challenges. J Neurochem (2012) 0.79
Surgical management of Parkinson's disease: update and review. Interv Neuroradiol (2008) 0.76
Deep brain stimulation-associated brain tissue imprints: a new in vivo approach to biological research in human Parkinson's disease. Mol Neurodegener (2016) 0.76
Deep Brain Stimulation in Huntington's Disease-Preliminary Evidence on Pathophysiology, Efficacy and Safety. Brain Sci (2016) 0.75
Improvement of Advanced Parkinson's Disease Manifestations with Deep Brain Stimulation of the Subthalamic Nucleus: A Single Institution Experience. Brain Sci (2016) 0.75
Microelectrode Guided Implantation of Electrodes into the Subthalamic Nucleus of Rats for Long-term Deep Brain Stimulation. J Vis Exp (2015) 0.75
Multi-Modal and Targeted Imaging Improves Automated Mid-Brain Segmentation. Proc SPIE Int Soc Opt Eng (2017) 0.75
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N Engl J Med (2000) 6.21
Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med (2001) 6.07
Parkinson's disease. First of two parts. N Engl J Med (1998) 5.90
Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet (2004) 5.06
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med (1998) 4.72
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain (2005) 4.33
Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet (1991) 3.89
Parkinson's disease. Second of two parts. N Engl J Med (1998) 3.46
Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg (1996) 3.37
Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med (1997) 3.23
The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthritis Cartilage (2011) 3.17
Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol (1987) 3.14
Predominant dystonia with marked cerebellar atrophy: a rare phenotype in familial dystonia. Neurology (2006) 3.07
Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet (1995) 3.06
Corticosteroid-dependent sodium transport in a novel immortalized mouse collecting duct principal cell line. J Am Soc Nephrol (1999) 2.88
Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression. Cereb Cortex (2007) 2.83
Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2002) 2.81
The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain (1994) 2.81
Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment. Mov Disord (1994) 2.77
Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology (2006) 2.70
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology (2003) 2.65
Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene. Oncogene (2001) 2.63
Manual motor performance in a deafferented man. Brain (1982) 2.63
The anatomical basis of symptomatic hemidystonia. Brain (1985) 2.60
How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain (2012) 2.52
Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. Brain (1986) 2.52
Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet (1995) 2.47
Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol (2001) 2.45
Focal dystonia of the jaw and the differential diagnosis of unilateral jaw and masticatory spasm. J Neurol Neurosurg Psychiatry (1986) 2.37
Mirror movements in parkinsonism: evaluation of a new clinical sign. J Neurol Neurosurg Psychiatry (2005) 2.35
Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain (2009) 2.35
ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells. Proc Natl Acad Sci U S A (1998) 2.34
Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain (2000) 2.25
The pedunculopontine nucleus and Parkinson's disease. Brain (2000) 2.21
Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol (1998) 2.21
Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry (2004) 2.21
Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology (1998) 2.19
Subthalamic deep brain stimulation at individualized frequencies for Parkinson disease. Neurology (2012) 2.18
Two highly homologous members of the ClC chloride channel family in both rat and human kidney. Proc Natl Acad Sci U S A (1994) 2.17
Hemichorea-hemiballism associated with hyperglycemia and a developmental venous anomaly. Neurology (2012) 2.14
The impact on Parkinson's disease of electrical parameter settings in STN stimulation. Neurology (2002) 2.14
A novel mouse Nedd4 protein suppresses the activity of the epithelial Na+ channel. FASEB J (2001) 2.13
Stereotactic targeting of the globus pallidus internus in Parkinson's disease: imaging versus electrophysiological mapping. Neurosurgery (1999) 2.13
Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology (2012) 2.12
Arm levitation in progressive supranuclear palsy. Neurology (1999) 2.06
Reciprocal inhibition between the muscles of the human forearm. J Physiol (1984) 2.05
Cortical-basal ganglionic degeneration. Neurology (1990) 2.04
High-frequency synchronization of neuronal activity in the subthalamic nucleus of parkinsonian patients with limb tremor. J Neurosci (2000) 2.04
Cloning and functional expression of rat CLC-5, a chloride channel related to kidney disease. J Biol Chem (1995) 2.00
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95
Role of resection and primary anastomosis of the left colon in the presence of peritonitis. Br J Surg (2000) 1.93
Pain-related neurons in the human cingulate cortex. Nat Neurosci (1999) 1.92
Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain (2009) 1.91
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology (2011) 1.90
Step initiation in Parkinson's disease: influence of levodopa and external sensory triggers. Mov Disord (1997) 1.90
Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology (2002) 1.89
Toll-like receptor 2 mediates early inflammation by leptospiral outer membrane proteins in proximal tubule cells. Kidney Int (2006) 1.89
Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet (2004) 1.88
Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology (1982) 1.88
Globus pallidus stimulation activates the cortical motor system during alleviation of parkinsonian symptoms. Nat Med (1997) 1.85
Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease. Neurology (2000) 1.85
MRI-guided STN DBS in Parkinson's disease without microelectrode recording: efficacy and safety. J Neurol Neurosurg Psychiatry (2010) 1.84
DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. Neurology (2004) 1.83
Phantom sensations generated by thalamic microstimulation. Nature (1998) 1.83
Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology (2010) 1.79
The 'essentials' of essential palatal tremor: a reappraisal of the nosology. Brain (2005) 1.78
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol (2009) 1.76
The impact of deep brain stimulation on executive function in Parkinson's disease. Brain (2000) 1.74
A multidisciplinary study of patients with early-onset PD with and without parkin mutations. Neurology (2008) 1.74
Severe tongue protrusion dystonia: clinical syndromes and possible treatment. Neurology (2006) 1.72
Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology (2006) 1.72
Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients. Brain (2008) 1.70
The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain (2001) 1.70
Single-voxel proton MR spectroscopy and positron emission tomography for lateralization of refractory temporal lobe epilepsy. AJNR Am J Neuroradiol (1998) 1.69
Globus pallidus internus pallidotomy for generalized dystonia. Mov Disord (1997) 1.69
[Infant crying diary: a useful aid in distinguishing between normal and excessive crying behavior]. Ned Tijdschr Geneeskd (2004) 1.69
Mechanism of the silent period following transcranial magnetic stimulation. Evidence from epidural recordings. Exp Brain Res (1999) 1.68